Acorda Therapeutics, Inc.
(NASDAQ : ACOR)

( )
ACOR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
LLYEli Lilly & Co. 0.13%365.731.1%$1198.66m
JNJJohnson & Johnson 0.02%177.270.7%$1105.44m
MRKMerck & Co., Inc. 0.87%108.430.7%$979.75m
PFEPfizer Inc. 0.78%49.600.9%$971.15m
ABBVAbbVie, Inc. -0.80%158.341.9%$838.84m
BMYBristol-Myers Squibb Co. -0.13%79.141.1%$734.71m
AZNAstraZeneca Plc 0.06%66.211.0%$359.51m
IDXXIDEXX Laboratories, Inc. -2.74%400.103.9%$216.62m
CTLTCatalent, Inc. 13.32%46.911.9%$200.95m
GSKGSK Plc -0.65%33.770.3%$199.83m
HZNPHorizon Therapeutics Plc -0.36%78.005.4%$196.93m
NVSNovartis AG -0.04%87.680.2%$186.54m
NVONovo Nordisk A/S 2.08%121.270.1%$162.88m
ALNYAlnylam Pharmaceuticals, Inc. -1.66%209.208.0%$139.45m
VTRSViatris, Inc. -0.72%11.060.0%$119.33m

Company Profile

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.